Dexmedetomidine for Sedation in Endoscopic Procedures
Author Information
Author(s): Abosheaishaa Hazem MD, MSc, Abdallfatah Abdallfatah MS, Abdelghany Abdelmalek MS, Sethi Arshia MD, Ismail Abdellatif MD, Mohamed Doha MS, Aboeldahb Moataz MD, Abdelhalim Omar MD, Mohamed Islam MD, Azzam Ahmed Y. MD, MEng, Essibayi Muhammed Amir MD, Altschul David J., Nassar Mahmoud MD, Bilal Mohammad MD
Primary Institution: Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals, Queens, New York, USA.
Hypothesis
Is dexmedetomidine an effective adjunctive sedative for patients undergoing endoscopic submucosal dissection?
Conclusion
Dexmedetomidine is safe and effective for sedation during endoscopic submucosal dissection, reducing restlessness without significant adverse events.
Supporting Evidence
- Dexmedetomidine significantly reduced restlessness compared to controls.
- Dexmedetomidine increased the risk of bradycardia.
- No significant difference in en-bloc or complete resection rates between dexmedetomidine and control groups.
- Sedation and procedure times were similar between dexmedetomidine and control groups.
Takeaway
Dexmedetomidine helps keep patients calm and comfortable during certain medical procedures without causing serious side effects.
Methodology
A systematic review and meta-analysis of studies involving dexmedetomidine as an adjunctive sedative during endoscopic submucosal dissection.
Potential Biases
Some studies had a moderate risk of bias, and most did not conduct head-to-head comparisons.
Limitations
The studies included were primarily from Eastern Asia, limiting generalizability, and there was no standardized dosage of dexmedetomidine.
Participant Demographics
Patients undergoing endoscopic submucosal dissection for gastrointestinal adenomas and early-stage neoplastic lesions.
Statistical Information
P-Value
p=0.52 for en-bloc resection, p=0.38 for complete resection, p=0.14 for sedation time, p=0.51 for procedure time, p<0.00001 for restlessness, p<0.00001 for bradycardia.
Confidence Interval
95% CI: 0.07 to 0.29 for restlessness, 95% CI: 3.17 to 16.11 for bradycardia.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website